Bicaval TricValve Implantation in Patients With Severe Tricuspid Regurgitation: 1-Year Outcomes From the TricBicaval Registry
Loading...
Identifiers
Publication date
Authors
Sánchez Recalde, Ángel
Domínguez Rodríguez, Luis Manuel
Rosseel, Liesbeth
Nombela Franco, Luis
Pfister, Roman
Advisors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
SDG
Metrics
Abstract
Caval valve implantation is currently the only alternative for patients with severe tricuspid regurgitation (TR) who are deemed unsuitable candidates for transcatheter orthotopic therapies.
The aim of this study was to assess the efficacy and safety of TricValve system at 1-year follow-up.
In this highly comorbid population with severe TR, caval valve implantation using the TricValve system led to significant 1-year clinical improvement, with mortality rates aligned with baseline TRI-SCORE.
Description
UNESCO Subjects
Keywords
Bibliographic reference
Sánchez-Recalde, A., Domínguez-Rodríguez, L. M., Rosseel, L., Nombela-Franco, L., Pfister, R., Amat-Santos, I., Butter, C., Di Mauro, M., Cruz-González, I., Freixa, X., Swaans, M., Wilde, C., Cacela, D., Sarnago, F., Del Trigo, M., Estévez-Loureiro, R., López-Mínguez, J. R., De Torres-Alba, F., Montenegro, M., … Zamorano, J. L. (2025). Bicaval tricvalve implantation in patients with severe tricuspid regurgitation. JACC: Cardiovascular Interventions, 18(15), 1913-1924. https://doi.org/10.1016/j.jcin.2025.06.023